The Hematologist
Un podcast de The Hematologist
150 Épisodes
-
The End of Transplant for Mantle Cell Lymphoma
Publié: 31/01/2025 -
DREAMMing of a Better Tomorrow: Belantamab-Based Triplet Therapy for Relapsed/Refractory Multiple Myeloma
Publié: 21/12/2024 -
Haploidentical Stem Cell Transplantation Is an Acceptable Transformative Therapy for Young Adults With Sickle Cell Disease
Publié: 27/11/2024 -
Enhancing Risk Stratification for Pediatric B-Cell Acute Lymphoblastic Leukemia: No Longer a ‘PI’ in the Sky Idea?
Publié: 11/10/2024 -
A Leap of Faith? Elimination of Autologous Stem Cell Transplantation for Patients With Mantle Cell Lymphoma in First Remission
Publié: 16/09/2024 -
Anticoagulation Stewardship
Publié: 29/08/2024 -
Blood Global Hematology Editor-in-Chief Shares Vision
Publié: 17/07/2024 -
One on One With Dr. Fred Appelbaum
Publié: 26/06/2024 -
Genetic Switch System Suggests Targeting of Mutant JAK2 Reverses Myeloproliferative Neoplasms
Publié: 21/06/2024 -
Venous Thromboembolism Risk Markers and Discontinuing Combined Hormonal Contraceptives
Publié: 07/05/2024 -
Growing the Next Generation of Hematologists
Publié: 15/04/2024 -
Women in Hematology
Publié: 26/03/2024 -
Four Is Better Than Three: Will We Finally Agree?
Publié: 18/03/2024 -
Toward Equity in Access for ALL
Publié: 30/01/2024 -
The Brilliant Success of Blinatumomab for Babies With Acute Lymphoblastic Leukemia
Publié: 29/11/2023 -
Editors-in-Chief of Two New ASH Journals Share Their Visions
Publié: 20/10/2023 -
ASH’s Minority Recruitment Initiative Mentorship Program Offers a Win for All
Publié: 18/09/2023 -
Results From the Blood and Marrow Transplant Trials Network: How Should We Prevent Graft-versus-host Disease in 2023?
Publié: 01/09/2023 -
Genetic Background Influences the Growth of CHIP Clones Within the Bone Marrow, With Drs. Robert Hasserjian and Siddhartha Jaiswal
Publié: 07/07/2023 -
Drawing New Blood Into Hematology
Publié: 16/06/2023
The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.
